247 related articles for article (PubMed ID: 17912358)
1. Germ line origin and somatic mutations determine the target tissues in systemic AL-amyloidosis.
Enqvist S; Sletten K; Stevens FJ; Hellman U; Westermark P
PLoS One; 2007 Oct; 2(10):e981. PubMed ID: 17912358
[TBL] [Abstract][Full Text] [Related]
2. Mutations in specific structural regions of immunoglobulin light chains are associated with free light chain levels in patients with AL amyloidosis.
Poshusta TL; Sikkink LA; Leung N; Clark RJ; Dispenzieri A; Ramirez-Alvarado M
PLoS One; 2009; 4(4):e5169. PubMed ID: 19365555
[TBL] [Abstract][Full Text] [Related]
3. Differential effects on light chain amyloid formation depend on mutations and type of glycosaminoglycans.
Blancas-Mejía LM; Hammernik J; Marin-Argany M; Ramirez-Alvarado M
J Biol Chem; 2015 Feb; 290(8):4953-4965. PubMed ID: 25538238
[TBL] [Abstract][Full Text] [Related]
4. Fatal amyloid formation in a patient's antibody light chain is caused by a single point mutation.
Kazman P; Vielberg MT; Pulido Cendales MD; Hunziger L; Weber B; Hegenbart U; Zacharias M; Köhler R; Schönland S; Groll M; Buchner J
Elife; 2020 Mar; 9():. PubMed ID: 32151314
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel substitution in the constant region of a gene coding for an amyloidogenic kappa1 light chain.
Wally J; Kica G; Zhang Y; Ericsson T; Connors LH; Benson MD; Liepnieks JJ; Murray J; Skinner M; Comenzo RL
Biochim Biophys Acta; 1999 May; 1454(1):49-56. PubMed ID: 10354514
[TBL] [Abstract][Full Text] [Related]
6. The tropism of organ involvement in primary systemic amyloidosis: contributions of Ig V(L) germ line gene use and clonal plasma cell burden.
Comenzo RL; Zhang Y; Martinez C; Osman K; Herrera GA
Blood; 2001 Aug; 98(3):714-20. PubMed ID: 11468171
[TBL] [Abstract][Full Text] [Related]
7. Altered dimer interface decreases stability in an amyloidogenic protein.
Baden EM; Owen BA; Peterson FC; Volkman BF; Ramirez-Alvarado M; Thompson JR
J Biol Chem; 2008 Jun; 283(23):15853-60. PubMed ID: 18400753
[TBL] [Abstract][Full Text] [Related]
8. Structural insights into the role of mutations in amyloidogenesis.
Baden EM; Randles EG; Aboagye AK; Thompson JR; Ramirez-Alvarado M
J Biol Chem; 2008 Nov; 283(45):30950-6. PubMed ID: 18768467
[TBL] [Abstract][Full Text] [Related]
9. Cryo-EM structure of a light chain-derived amyloid fibril from a patient with systemic AL amyloidosis.
Radamaker L; Lin YH; Annamalai K; Huhn S; Hegenbart U; Schönland SO; Fritz G; Schmidt M; Fändrich M
Nat Commun; 2019 Mar; 10(1):1103. PubMed ID: 30894526
[TBL] [Abstract][Full Text] [Related]
10. Analysis of somatic hypermutation and antigenic selection in the clonal B cell in immunoglobulin light chain amyloidosis (AL).
Abraham RS; Geyer SM; Ramírez-Alvarado M; Price-Troska TL; Gertz MA; Fonseca R
J Clin Immunol; 2004 Jul; 24(4):340-53. PubMed ID: 15163890
[TBL] [Abstract][Full Text] [Related]
11. Stability and aggregation propensity do not fully account for the association of various germline variable domain gene segments with light chain amyloidosis.
Garay Sánchez SA; Rodríguez Álvarez FJ; Zavala-Padilla G; Mejia-Cristobal LM; Cruz-Rangel A; Costas M; Fernández Velasco DA; Melendez-Zajgla J; Del Pozo-Yauner L
Biol Chem; 2017 Apr; 398(4):477-489. PubMed ID: 27935845
[TBL] [Abstract][Full Text] [Related]
12. Light chain amyloidosis - current findings and future prospects.
Baden EM; Sikkink LA; Ramirez-Alvarado M
Curr Protein Pept Sci; 2009 Oct; 10(5):500-508. PubMed ID: 19538145
[TBL] [Abstract][Full Text] [Related]
13. Dissecting the Molecular Features of Systemic Light Chain (AL) Amyloidosis: Contributions from Proteomics.
Rognoni P; Mazzini G; Caminito S; Palladini G; Lavatelli F
Medicina (Kaunas); 2021 Aug; 57(9):. PubMed ID: 34577839
[TBL] [Abstract][Full Text] [Related]
14. Light chain mutations contribute to defining the fibril morphology in systemic AL amyloidosis.
Karimi-Farsijani S; Pfeiffer PB; Banerjee S; Baur J; Kuhn L; Kupfer N; Hegenbart U; Schönland SO; Wiese S; Haupt C; Schmidt M; Fändrich M
Nat Commun; 2024 Jun; 15(1):5121. PubMed ID: 38879609
[TBL] [Abstract][Full Text] [Related]
15. A glycosylated Bence Jones protein and its autologous amyloid light chain containing potentially amyloidogenic residues.
Foss GS; Nilsen R; Cornwell GC; Husby G; Sletten K
Scand J Immunol; 1998 Apr; 47(4):348-54. PubMed ID: 9600316
[TBL] [Abstract][Full Text] [Related]
16. A single mutation promotes amyloidogenicity through a highly promiscuous dimer interface.
Peterson FC; Baden EM; Owen BA; Volkman BF; Ramirez-Alvarado M
Structure; 2010 May; 18(5):563-70. PubMed ID: 20462490
[TBL] [Abstract][Full Text] [Related]
17. Identification and location of a cysteinyl posttranslational modification in an amyloidogenic kappa1 light chain protein by electrospray ionization and matrix-assisted laser desorption/ionization mass spectrometry.
Lim A; Wally J; Walsh MT; Skinner M; Costello CE
Anal Biochem; 2001 Aug; 295(1):45-56. PubMed ID: 11476544
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin light chain amyloid aggregation.
Blancas-Mejia LM; Misra P; Dick CJ; Cooper SA; Redhage KR; Bergman MR; Jordan TL; Maar K; Ramirez-Alvarado M
Chem Commun (Camb); 2018 Sep; 54(76):10664-10674. PubMed ID: 30087961
[TBL] [Abstract][Full Text] [Related]
19. The amino acid sequence of the glycosylated amyloid immunoglobulin light chain protein AL MS.
Omtvedt LA; Husby G; Cornwell GG; Kyle RA; Sletten K
Scand J Immunol; 1997 May; 45(5):551-6. PubMed ID: 9160102
[TBL] [Abstract][Full Text] [Related]
20. Amyloid fibril composition and transthyretin gene structure in senile systemic amyloidosis.
Gustavsson A; Jahr H; Tobiassen R; Jacobson DR; Sletten K; Westermark P
Lab Invest; 1995 Nov; 73(5):703-8. PubMed ID: 7474944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
